Comments
Alembic Pharmaceuticals on Friday said that it has received Establishment Inspection Report (EIR) from the US Food & Drug Administration (USFDA) for its formulations facility at Panelav, Gujarat. The inspection was carried out by the regulator during October 22 and 25, 2018. Shares of Alembic Pharmaceuticals ended flat at ₹ 538.15 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.